Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Foster

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|October 27, 2004
The analgesic potential of clostridial neurotoxin derivativesKeith A Foster
Drug Discovery Today|April 20, 2005
A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesicsKeith A Foster
Toxicon : Official Journal of the International Society on Toxinology|March 7, 2009
Engineered toxins: new therapeuticsKeith A Foster
Drug Discovery Today|September 26, 2009
Biologics: a new approach needed?Keith A Foster
Annual Review of Pharmacology and Toxicology|September 11, 2013
Engineered botulinum neurotoxins as new therapeuticsGeoffrey Masuyer, John A Chaddock, Keith A Foster, et al.
The FEBS Journal|December 7, 2011
Engineering botulinum neurotoxin domains for activation by toxin light chainPatrick R Stancombe, Geoffrey Masuyer, Ian Birch-Machin, et al.
Journal of Immunological Methods|June 9, 2004
Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodiesYper H J Hall, John A Chaddock, Hilary J Moulsdale, et al.
Journal of Pain Research|November 18, 2011
Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neuronsYiangos Yiangou, Uma Anand, William R Otto, et al.
Protein Expression and Purification|July 24, 2002
Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type AJohn A Chaddock, Michael H Herbert, Roger J Ling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of painJohn A Chaddock, John R Purkiss, Frances C G Alexander, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|October 27, 2004
The analgesic potential of clostridial neurotoxin derivativesKeith A Foster
Drug Discovery Today|April 20, 2005
A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesicsKeith A Foster
Toxicon : Official Journal of the International Society on Toxinology|March 7, 2009
Engineered toxins: new therapeuticsKeith A Foster
Drug Discovery Today|September 26, 2009
Biologics: a new approach needed?Keith A Foster
Annual Review of Pharmacology and Toxicology|September 11, 2013
Engineered botulinum neurotoxins as new therapeuticsGeoffrey Masuyer, John A Chaddock, Keith A Foster, et al.
The FEBS Journal|December 7, 2011
Engineering botulinum neurotoxin domains for activation by toxin light chainPatrick R Stancombe, Geoffrey Masuyer, Ian Birch-Machin, et al.
Journal of Immunological Methods|June 9, 2004
Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodiesYper H J Hall, John A Chaddock, Hilary J Moulsdale, et al.
Journal of Pain Research|November 18, 2011
Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neuronsYiangos Yiangou, Uma Anand, William R Otto, et al.
Protein Expression and Purification|July 24, 2002
Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type AJohn A Chaddock, Michael H Herbert, Roger J Ling, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of painJohn A Chaddock, John R Purkiss, Frances C G Alexander, et al.
Pageof 2